| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Richard Holdman, Daniel Vigil, Kelsey Robinson, Puja Shah, Alexandra Elyse Contrera. Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications. Cannabis and cannabinoid research. 2021-08-25. PMID:34432543. |
safety and efficacy of medical cannabis in autism spectrum disorder compared with commonly used medications. |
2021-08-25 |
2023-08-13 |
Not clear |
| Estácio Amaro da Silva, Wandersonia Moreira Brito Medeiros, Nelson Torro, João Marçal Medeiros de Sousa, Igor Bronzeado Cahino Moura de Almeida, Filipe Barbosa da Costa, Katiúscia Moreira Pontes, Eliane Lima Guerra Nunes, Marine Diniz da Rosa, Katy Lísias Gondim Dias de Albuquerqu. Cannabis and cannabinoid use in autism spectrum disorder: a systematic review. Trends in psychiatry and psychotherapy. 2021-05-27. PMID:34043900. |
cannabis and cannabinoid use in autism spectrum disorder: a systematic review. |
2021-05-27 |
2023-08-13 |
Not clear |
| Sarah Fletcher, Colleen Pawliuk, Angie Ip, Tim Oberlander, Harold Side. Symptoms, adverse events, and outcomes in the use of medicinal cannabis in children and adolescents with autism spectrum disorder: a scoping review protocol. JBI evidence synthesis. vol 19. issue 5. 2021-05-21. PMID:33165173. |
symptoms, adverse events, and outcomes in the use of medicinal cannabis in children and adolescents with autism spectrum disorder: a scoping review protocol. |
2021-05-21 |
2023-08-13 |
Not clear |
| Sarah Fletcher, Colleen Pawliuk, Angie Ip, Tim Oberlander, Harold Side. Symptoms, adverse events, and outcomes in the use of medicinal cannabis in children and adolescents with autism spectrum disorder: a scoping review protocol. JBI evidence synthesis. vol 19. issue 5. 2021-05-21. PMID:33165173. |
the objective of this scoping review is to map and identify the symptoms, adverse events, and outcomes in the use of medicinal cannabis in children and adolescents with autism spectrum disorder. |
2021-05-21 |
2023-08-13 |
Not clear |
| Rose Schrott, Kelly Acharya, Nilda Itchon-Ramos, Andrew B Hawkey, Erica Pippen, John T Mitchell, Scott H Kollins, Edward D Levin, Susan K Murph. Cannabis use is associated with potentially heritable widespread changes in autism candidate gene Epigenetics. vol 15. issue 1-2. 2021-04-21. PMID:31451081. |
cannabis use is associated with potentially heritable widespread changes in autism candidate gene parental cannabis use has been associated with adverse neurodevelopmental outcomes in offspring, but how such phenotypes are transmitted is largely unknown. |
2021-04-21 |
2023-08-13 |
human |
| Abhinaya Ganesh, Safiullah Sharee. Safety and Efficacy of Cannabis in Autism Spectrum Disorder. Pediatric neurology briefs. vol 34. 2020-12-31. PMID:33376294. |
safety and efficacy of cannabis in autism spectrum disorder. |
2020-12-31 |
2023-08-13 |
Not clear |
| Abhinaya Ganesh, Safiullah Sharee. Safety and Efficacy of Cannabis in Autism Spectrum Disorder. Pediatric neurology briefs. vol 34. 2020-12-31. PMID:33376294. |
investigators from the soroka university medical centre, the hebrew university of jerusalem, and tikun olam ltd. in israel studied the safety and efficacy of medical cannabis treatment on 188 patients with autism spectrum disorder (asd) for six months. |
2020-12-31 |
2023-08-13 |
Not clear |
| Dana Barchel, Orit Stolar, Tal De-Haan, Tomer Ziv-Baran, Naama Saban, Danny Or Fuchs, Gideon Koren, Matitiahu Berkovitc. Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities. Frontiers in pharmacology. vol 9. 2020-10-01. PMID:30687090. |
oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and co-morbidities. |
2020-10-01 |
2023-08-13 |
Not clear |
| Carlos A Salgado, Daniel Castellano. Autism Spectrum Disorder and Cannabidiol: Have We Seen This Movie Before? Global pediatric health. vol 5. 2020-09-29. PMID:30547057. |
autism spectrum disorder and cannabidiol: have we seen this movie before? |
2020-09-29 |
2023-08-13 |
Not clear |
| Adi Aran, Dalit Cayam-Ran. Medical Cannabis in Children. Rambam Maimonides medical journal. vol 11. issue 1. 2020-09-28. PMID:32017680. |
while robust evidence currently exists only for pure cannabidiol (cbd) to treat specific types of refractory epilepsy, in most cases, artisanal strains of cbd-rich medical cannabis are being used to treat children with various types of refractory epilepsy or irritability associated with autism spectrum disorder (asd). |
2020-09-28 |
2023-08-13 |
Not clear |
| Shawn Y Forrester, Nusrat Jaha. Depression Onset in Long-term Adolescent Cannabinoid Use: A Neurobiological Review. Cureus. vol 12. issue 4. 2020-09-28. PMID:32455076. |
data were included from studies that satisfied the following criteria: (i) published within the last 10 years (older studies were included based on relevance), (ii) on adolescent subjects (animal or human), (iii) published in english, (iv) journal articles, systematic reviews, meta-analyses, clinical trials, observational studies (animal or human), (v) on subjects who had unipolar depression with no comorbidities, and (vi) on subjects who used cannabis [with no confounding variables such as the use of ethanol, nicotine, cocaine, lysergic acid diethylamide (lsd), and heroin; and no medical conditions such as comorbid psychosis, mania, or autism]. |
2020-09-28 |
2023-08-13 |
human |
| Charlotte M Pretzsch, Bogdan Voinescu, Maria A Mendez, Robert Wichers, Laura Ajram, Glynis Ivin, Martin Heasman, Steven Williams, Declan Gm Murphy, Eileen Daly, Gráinne M McAlona. The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD). Journal of psychopharmacology (Oxford, England). vol 33. issue 9. 2020-08-12. PMID:31237191. |
the effect of cannabidiol (cbd) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (asd). |
2020-08-12 |
2023-08-13 |
Not clear |
| Charlotte M Pretzsch, Bogdan Voinescu, Maria A Mendez, Robert Wichers, Laura Ajram, Glynis Ivin, Martin Heasman, Steven Williams, Declan Gm Murphy, Eileen Daly, Gráinne M McAlona. The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD). Journal of psychopharmacology (Oxford, England). vol 33. issue 9. 2020-08-12. PMID:31237191. |
the potential benefits of cannabis and its major non-intoxicating component cannabidiol (cbd) are attracting attention, including as a potential treatment in neurodevelopmental disorders such as autism spectrum disorder (asd). |
2020-08-12 |
2023-08-13 |
Not clear |
| Lihi Bar-Lev Schleider, Raphael Mechoulam, Naama Saban, Gal Meiri, Victor Novac. Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy. Scientific reports. vol 9. issue 1. 2020-04-30. PMID:30655581. |
real life experience of medical cannabis treatment in autism: analysis of safety and efficacy. |
2020-04-30 |
2023-08-13 |
Not clear |
| Charlotte Marie Pretzsch, Jan Freyberg, Bogdan Voinescu, David Lythgoe, Jamie Horder, Maria Andreina Mendez, Robert Wichers, Laura Ajram, Glynis Ivin, Martin Heasman, Richard A E Edden, Steven Williams, Declan G M Murphy, Eileen Daly, Gráinne M McAlona. Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 44. issue 8. 2020-03-31. PMID:30758329. |
effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder. |
2020-03-31 |
2023-08-13 |
Not clear |
| Charlotte Marie Pretzsch, Jan Freyberg, Bogdan Voinescu, David Lythgoe, Jamie Horder, Maria Andreina Mendez, Robert Wichers, Laura Ajram, Glynis Ivin, Martin Heasman, Richard A E Edden, Steven Williams, Declan G M Murphy, Eileen Daly, Gráinne M McAlona. Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 44. issue 8. 2020-03-31. PMID:30758329. |
there is increasing interest in the use of cannabis and its major non-intoxicating component cannabidiol (cbd) as a treatment for mental health and neurodevelopmental disorders, such as autism spectrum disorder (asd). |
2020-03-31 |
2023-08-13 |
Not clear |
| Kamalaker Dadi, Mehdi Rahim, Alexandre Abraham, Darya Chyzhyk, Michael Milham, Bertrand Thirion, Gaël Varoquau. Benchmarking functional connectome-based predictive models for resting-state fMRI. NeuroImage. vol 192. 2019-12-20. PMID:30836146. |
we systematically study the prediction performances of models in 6 different cohorts and a total of 2000 individuals, encompassing neuro-degenerative (alzheimer's, post-traumatic stress disorder), neuro-psychiatric (schizophrenia, autism), drug impact (cannabis use) clinical settings and psychological trait (fluid intelligence). |
2019-12-20 |
2023-08-13 |
human |
| Adi Aran, Hanoch Cassuto, Asael Lubotzky, Nadia Wattad, Esther Haza. Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study. Journal of autism and developmental disorders. vol 49. issue 3. 2019-04-16. PMID:30382443. |
brief report: cannabidiol-rich cannabis in children with autism spectrum disorder and severe behavioral problems-a retrospective feasibility study. |
2019-04-16 |
2023-08-13 |
Not clear |
| Adi Aran, Hanoch Cassuto, Asael Lubotzky, Nadia Wattad, Esther Haza. Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study. Journal of autism and developmental disorders. vol 49. issue 3. 2019-04-16. PMID:30382443. |
anecdotal evidence of successful cannabis treatment in autism spectrum disorder (asd) are accumulating but clinical studies are lacking. |
2019-04-16 |
2023-08-13 |
Not clear |
| Shani Poleg, Pavel Golubchik, Daniel Offen, Abraham Weizma. Cannabidiol as a suggested candidate for treatment of autism spectrum disorder. Progress in neuro-psychopharmacology & biological psychiatry. vol 89. 2019-03-25. PMID:30171992. |
cannabidiol as a suggested candidate for treatment of autism spectrum disorder. |
2019-03-25 |
2023-08-13 |
Not clear |